Skip to main content
. 2017 Jan 1;8(1):104–110. doi: 10.7150/jca.16856

Figure 3.

Figure 3

Association of FR+-CTC with TNM stage and histopathologic subtypes of lung cancer patients. (A) The FR+-CTC level in lung cancer patients with different TNM stages. (B) The FR+-CTC level between patients with NSCLC and SCLC. NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer. (C) The FR+-CTC level between patients with ADC and SCC. ADC, adenocarcinoma; SCC, squamous cell carcinoma.